MicroRNAs and lipoprotein metabolism

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 1, 2014, Pages 17-22

  Horie, Takahiro ^a   Baba, Osamu ^a   Kuwabara, Yasuhide ^a   Yokode, Masayuki ^a   Kita, Toru ^b   Kimura, Takeshi ^a   Ono, Koh ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Atherosclerosis; HDL C; MicroRNA

Indexed keywords

DIACYLGLYCEROL ACYLTRANSFERASE 2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MICRORNA; MICRORNA 122; STEROL REGULATORY ELEMENT BINDING PROTEIN;

3' UNTRANSLATED REGION; ATHEROSCLEROSIS; HUMAN; LIPID METABOLISM; LIPOPROTEIN METABOLISM; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; REVIEW; UPREGULATION;

ADIPOGENESIS; ANIMALS; ATHEROSCLEROSIS; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; LIPOPROTEINS; MICRORNAS;

EID: 84892996415     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.20859     Document Type: Review

References (38)

1. Bartel DP: Micrornas: Genomics, biogenesis, mechanism, and function. Cell, 2004; 116: 281-297
2. Ambros V: The functions of animal micrornas. Nature, 2004; 431: 350-355
3. Lee RC, Feinbaum RL, Ambros V: The c. Elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell, 1993; 75: 843-854
4. Wightman B, Ha I, Ruvkun G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in c. Elegans. Cell, 1993; 75: 855-862
5. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell, 2005; 120: 15-20
6. Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mrnas are conserved targets of micrornas. Genome Res, 2009; 19: 92-105
7. Kozomara A, Griffiths-Jones S: Mirbase: Integrating microrna annotation and deep-sequencing data. Nucleic Acids Res, 2011; 39: D152-157
8. Rottiers V, Naar AM: Micrornas in metabolism and metabolic disorders. Nat Rev Mol Cell Biol, 2012; 13: 239-250
9. Moore KJ, Rayner KJ, Suarez Y, Fernandez-Hernando C: Micrornas and cholesterol metabolism. Trends Endocrinol Metab, 2010; 21: 699-706
10. Norata GD, Sala F, Catapano AL, Fernandez-Hernando C: Micrornas and lipoproteins: A connection beyond atherosclerosis? Atherosclerosis, 2013; 227: 209-215
11. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M: Silencing of micrornas in vivo with 'antagomirs'. Nature, 2005; 438: 685-689
12. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP: Mir-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab, 2006; 3: 87-98
13. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjarn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S: Lna-mediated microrna silencing in non-human primates. Nature, 2008; 452: 896-899
14. Wen J, Friedman JR: Mir-122 regulates hepatic lipid metabolism and tumor suppression. J Clin Invest, 2012; 122: 2773-2776
15. Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, Yu L, Bai S, La Perle K, Chivukula RR, Mao H, Wei M, Clark KR, Mendell JR, Caligiuri MA, Jacob ST, Mendell JT, Ghoshal K: Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of mir-122 in liver. J Clin Invest, 2012; 122: 2871-2883
16. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernandez-Hernando C: Mir-33 contributes to the regulation of cholesterol homeostasis. Science, 2010; 328: 1570-1573
17. Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Naar AM: Microrna-33 and the srebp host genes cooperate to control cholesterol homeostasis. Science, 2010; 328: 1566-1569
18. Marquart TJ, Allen RM, Ory DS, Baldan A: Mir-33 links srebp-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A, 2010; 107: 12228-12232
19. Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, Kinoshita M, Kuwabara Y, Marusawa H, Iwanaga Y, Hasegawa K, Yokode M, Kimura T, Kita T: Microrna-33 encoded by an intron of sterol regulatory element-binding protein 2 (srebp2) regulates hdl in vivo. Proc Natl Acad Sci U S A, 2010; 107: 17321-17326
20. Gerin I, Clerbaux LA, Haumont O, Lanthier N, Das AK, Burant CF, Leclercq IA, MacDougald OA, Bommer GT: Expression of mir-33 from an srebp2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem, 2010; 285: 33652-33661
21. Brown MS, Ye J, Goldstein JL: Medicine. Hdl mir-ed down by srebp introns. Science, 2010; 328: 1495-1496
22. Brown MS, Goldstein JL: The srebp pathway: Regulation of cholesterol metabolism by proteolysis of a membranebound transcription factor. Cell, 1997; 89: 331-340
23. Horton JD, Shimomura I: Sterol regulatory elementbinding proteins: Activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol, 1999; 10: 143-150
24. Horton JD, Goldstein JL, Brown MS: Srebps: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest, 2002; 109: 1125-1131
25. Allen RM, Marquart TJ, Albert CJ, Suchy FJ, Wang DQ, Ananthanarayanan M, Ford DA, Baldan A: Mir-33 controls the expression of biliary transporters, and mediates statin-and diet-induced hepatotoxicity. EMBO Mol Med, 2012; 4: 882-895
26. Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y, Fernandez-Hernando C, Fisher EA, Moore KJ: Antagonism of mir-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest, 2011; 121: 2921-2931
27. Horie T, Baba O, Kuwabara Y, Chujo Y, Watanabe S, Kinoshita M, Horiguchi M, Nakamura T, Chonabayashi K, Hishizawa M, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, Ono K: Microrna-33 deficiency reduces the progression of atherosclerotic plaque in apoe(-/-) mice. J Am Heart Assoc, 2012; 1: e003376
28. Marquart TJ, Wu J, Lusis AJ, Baldan A: Anti-mir-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol, 2013; 33: 455-458
29. Rotllan N, Ramirez CM, Aryal B, Esau CC, Fernandez-Hernando C: Therapeutic silencing of microrna-33 inhibits the progression of atherosclerosis in ldlr-/-mice--brief report. Arterioscler Thromb Vasc Biol, 2013; 33: 1973-1977
30. Davalos A, Goedeke L, Smibert P, Ramirez CM, Warrier NP, Andreo U, Cirera-Salinas D, Rayner K, Suresh U, Pastor-Pareja JC, Esplugues E, Fisher EA, Penalva LO, Moore KJ, Suarez Y, Lai EC, Fernandez-Hernando C: Mir-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A, 2011; 108: 9232-9237
31. Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM, Ray TD, Sheedy FJ, Goedeke L, Liu X, Khatsenko OG, Kaimal V, Lees CJ, Fernandez-Hernando C, Fisher EA, Temel RE, Moore KJ: Inhibition of mir-33a/b in non-human primates raises plasma hdl and lowers vldl triglycerides. Nature, 2011; 478: 404-407
32. Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI: Microrna-370 controls the expression of microrna-122 and cpt1alpha and affects lipid metabolism. J Lipid Res, 2010; 51: 1513-1523
33. Ramirez CM, Davalos A, Goedeke L, Salerno AG, Warrier N, Cirera-Salinas D, Suarez Y, Fernandez-Hernando C: Microrna-758 regulates cholesterol efflux through posttranscriptional repression of atp-binding cassette transporter a1. Arterioscler Thromb Vasc Biol, 2011; 31: 2707-2714
34. Sun D, Zhang J, Xie J, Wei W, Chen M, Zhao X: Mir-26 controls lxr-dependent cholesterol efflux by targeting abca1 and arl7. FEBS Lett, 2012; 586: 1472-1479
35. Kim J, Yoon H, Ramirez CM, Lee SM, Hoe HS, Fernandez-Hernando C: Mir-106b impairs cholesterol efflux and increases abeta levels by repressing abca1 expression. Exp Neurol, 2012; 235: 476-483
36. de Aguiar Vallim TQ, Tarling EJ, Kim T, Civelek M, Baldan A, Esau C, Edwards PA: Microrna-144 regulates hepatic atp binding cassette transporter a1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid x receptor. Circ Res, 2013; 112: 1602-1612
37. Ramirez CM, Rotllan N, Vlassov AV, Davalos A, Li M, Goedeke L, Aranda JF, Cirera-Salinas D, Araldi E, Salerno A, Wanschel A, Zavadil J, Castrillo A, Kim J, Suarez Y, Fernandez-Hernando C: Control of cholesterol metabolism and plasma high-density lipoprotein levels by microrna-144. Circ Res, 2013; 112: 1592-1601
38. Soh J, Iqbal J, Queiroz J, Fernandez-Hernando C, Hussain MM: Microrna-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat Med, 2013; 19: 892-900